Filings For: Avricore Health Inc.
WHO USES CALCBENCH?    Equity Analysts    Corparate Finance & Reporting    Auditors    Academics

GO TO: Recent Comment Letters


Today


ALL   |    All 10-K/Qs   Large   Mid    Small    Micro    |     Earnings Release    Proxy    |   SORT BY :   Most Recent    Company Name 
CompanyTimeSizeViewFinancialsDocumentSECPeriodRevenue MRQAssetsEPS Diluted
Avricore Health Inc. (AVCR) 11/6/2026 5:11:17 PM Micro View Financials 20-F SEC Y 2025 ending: 12/31/2025 Rev: $382,208 -89.1% Assets $410,687 EPS -$0.01
Avricore Health Inc. (AVCR) 6/16/2025 4:44:47 PM Micro View Financials 20-F SEC Y 2024 ending: 12/31/2024 Rev: $3,494,526 +35.3% Assets $1,596,109 EPS -$0.01
Avricore Health Inc. (AVCR) 6/12/2024 2:15:22 PM Micro View Financials 20-F SEC Y 2023 ending: 12/31/2023 Rev: $2,583,191 +89.9% Assets $1,922,690 EPS -$0.01
Avricore Health Inc. (AVCR) 6/16/2023 6:26:01 AM Micro View Financials 20-F SEC Y 2022 ending: 12/31/2022 Rev: $1,360,056 +1,287.6% Assets $1,898,478 EPS -$0.01
Avricore Health Inc. (AVCR) 12/20/2022 6:25:25 AM Micro View Financials 20-F SEC Y 2021 ending: 12/31/2021 Rev: $98,013 +297.9% Assets $1,785,646 EPS -$0.02
Avricore Health Inc. (AVCR) 6/23/2021 5:14:11 PM Micro View Financials 20-F SEC Y 2020 ending: 12/31/2020 Rev: $24,630 -1.0% Assets $345,075
Avricore Health Inc. (AVCR) 12/8/2020 12:57:00 PM Micro View Financials 20-F SEC Y 2019 ending: 12/31/2019
Avricore Health Inc. (AVCR) 6/17/2019 5:05:42 PM Micro View Financials 20-F SEC Y 2018 ending: 12/31/2018
Vanc Pharmaceuticals Inc. (AVCR) 6/19/2018 6:07:34 AM Micro View Financials 20-F/A SEC Y 2017 ending: 12/31/2017